Royal Bank of Canada’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $725K | Buy |
194,345
+188,717
| +3,353% | +$704K | ﹤0.01% | 3867 |
|
|
2025
Q1 | $15K | Sell |
5,628
-4,334
| -44% | -$11.6K | ﹤0.01% | 5646 |
|
|
2024
Q4 | $55K | Buy |
9,962
+2,282
| +30% | +$12.6K | ﹤0.01% | 5161 |
|
|
2024
Q3 | $65K | Sell |
7,680
-181
| -2% | -$1.53K | ﹤0.01% | 5119 |
|
|
2024
Q2 | $54K | Buy |
7,861
+4,279
| +119% | +$29.4K | ﹤0.01% | 5231 |
|
|
2024
Q1 | $24K | Sell |
3,582
-10,860
| -75% | -$72.8K | ﹤0.01% | 5404 |
|
|
2023
Q4 | $93K | Sell |
14,442
-26,748
| -65% | -$172K | ﹤0.01% | 5133 |
|
|
2023
Q3 | $207K | Sell |
41,190
-43,789
| -52% | -$220K | ﹤0.01% | 4296 |
|
|
2023
Q2 | $744K | Buy |
84,979
+34,975
| +70% | +$306K | ﹤0.01% | 3245 |
|
|
2023
Q1 | $592K | Buy |
50,004
+49,822
| +27,375% | +$590K | ﹤0.01% | 3386 |
|
|
2022
Q4 | $2K | Buy |
+182
| New | +$2K | ﹤0.01% | 6471 |
|
|
2022
Q2 | – | Sell |
-843
| Closed | -$3K | – | 7131 |
|
|
2022
Q1 | $3K | Sell |
843
-2,231
| -73% | -$7.94K | ﹤0.01% | 6916 |
|
|
2021
Q4 | $22K | Buy |
3,074
+1,323
| +76% | +$9.47K | ﹤0.01% | 6235 |
|
|
2021
Q3 | $18K | Buy |
1,751
+1,155
| +194% | +$11.9K | ﹤0.01% | 6223 |
|
|
2021
Q2 | $7K | Sell |
596
-198
| -25% | -$2.33K | ﹤0.01% | 6481 |
|
|
2021
Q1 | $17K | Buy |
+794
| New | +$17K | ﹤0.01% | 6031 |
|